BMO Capital Maintains Market Perform on Ingevity, Raises Price Target to $47
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst John McNulty maintains a Market Perform rating on Ingevity (NYSE:NGVT) and raises the price target from $40 to $47.
October 31, 2024 | 1:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BMO Capital has maintained its Market Perform rating on Ingevity and increased the price target from $40 to $47, indicating a positive outlook.
The increase in price target from $40 to $47 by BMO Capital suggests a positive outlook for Ingevity, which could lead to a short-term increase in stock price. The Market Perform rating indicates a neutral stance, but the raised target price is a positive signal.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100